Kailera Therapeutics, Inc. (KLRA)
16.40
+1.00
(+6.46%)
USD |
NASDAQ |
Sep 01, 16:00
16.40
0.00 (0.00%)
After-Hours: 17:23
Kailera Therapeutics Total Long Term Debt (Quarterly) : 9.166M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.166M |
| March 31, 2026 | 9.443M |
| Date | Value |
|---|---|
| June 30, 2025 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Moderna, Inc. | 1.266B |
| Revolution Medicines, Inc. | 1.174B |
| Sana Biotechnology, Inc. | 59.23M |
| Parabilis Medicines, Inc. | 34.21M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |